Patients

Patients and Data

The Prostate biobank is currently collecting samples and data from approximately 300 patients undergoing radical prostatectomy annually. As of August 2017, the biobank contains 2500 FFPE samples and 1300 FF samples.

Number of patients (serum samples) linked to PSA subgroups
PSA PSA <10 10< PSA >20 PSA >20 Total
n= 751 370 86 1207
Number of patients (serum samples) linked to clinical subgroups
Gleason biopsy 1 2 3 4 5 Total
n= 508 413 140 129 17 1207
Gleason RP 1 2 3 4 5 Total
n= 381 476 219 94 31 1207
pT-stage pT1c pT2 pT3a pT3b pT4 Total
n= 4 710 384 103 2 1207

The Prostate Biobank study has approvals and consent is in place to retrieve and link data also to a range of nationwide and mandatory registries such as the Cancer Registry of Norway, The Norwegian Cause of Death Registry (NCoDR), The Norwegian Prescription Database (NorPD) and The Norwegian Patient Registry (NPR). Deeper-level clinical and phenotype data can also be obtained directly from hospital EMRs.